Showing results (71-80 of 395) with videos related to
Sort By:
Pageof 40
Journal of Gastroenterology and Hepatology|February 24, 2001
Aortic hyporeactivity to norepinephrine induced by lipopolysaccharide in cirrhotic rats: beneficial effects of a non-steroidal anti-inflammatory drug coupled with a nitric oxide donorP Lefilliatre, P Sogni, V Bertrand, et al.Journal of Hepatology|April 1, 1994
Hemodynamic effects of acute administration of furosemide in patients with cirrhosis receiving beta-adrenergic antagonistsP Sogni, T Soupison, R Moreau, et al.Hepatology (Baltimore, Md.)|October 26, 2000
Evidence for an endothelium-derived hyperpolarizing factor in the superior mesenteric artery from rats with cirrhosisE Barriere, K A Tazi, J P Rona, et al.Journal of Gastroenterology and Hepatology|January 26, 1999
In vitro and in vivo vascular responses to the L-type calcium channel activator, Bay K 8644, in rats with cirrhosisR Moreau, F Oberti, P Lahaye, et al.European Journal of Pharmacology|May 7, 1998
Acute and chronic haemodynamic effects of naftazone in portal hypertensive ratsP Sogni, S Yang, C Pilette, et al.Journal of Hepatology|November 21, 1998
Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndromeA Hadengue, A Gadano, R Moreau, et al.Hepatology (Baltimore, Md.)|October 1, 1992
Evidence for normal nitric oxide-mediated vasodilator tone in conscious rats with cirrhosisP Sogni, R Moreau, M Ohsuga, et al.Hepatology (Baltimore, Md.)|September 10, 1998
Beneficial hemodynamic effects of bosentan, a mixed ET(A) and ET(B) receptor antagonist, in portal hypertensive ratsP Sogni, R Moreau, A Gomola, et al.Journal of Hepatology|February 15, 2000
Aquaretic effects of niravoline, a kappa-opioid agonist, in patients with cirrhosisA Gadano, R Moreau, F Pessione, et al.Liver|October 10, 1998
Influence of transjugular intrahepatic portosystemic shunts (TIPS) on tissue oxygenation in patients with cirrhosisC Denié, F Vachiéry, A Gadano, et al.Pageof 40